Introducing our Anti-Tupaia chinensis CD274/PD-L1/B7-H1 Polyclonal Antibody – a powerful tool for your biotech research needs.
This polyclonal antibody specifically targets the CD274/PD-L1/B7-H1 protein, which plays a crucial role in regulating immune responses. By binding to this protein, our antibody blocks its inhibitory function, allowing for enhanced immune activity.
Our Anti-Tupaia chinensis CD274/PD-L1/B7-H1 Polyclonal Antibody has a wide range of applications in the field of biotechnology. It has been extensively tested in various cell lines and animal models, demonstrating its effectiveness in both in vitro and in vivo studies.
One of the main applications of this antibody is in cancer research. CD274/PD-L1/B7-H1 is known to be overexpressed in many types of cancer, leading to immune evasion and tumor progression. Our antibody can help researchers better understand the mechanisms behind this process and potentially develop new therapies targeting this protein.
In addition, our Anti-Tupaia chinensis CD274/PD-L1/B7-H1 Polyclonal Antibody can also be used in autoimmune disease research. By blocking the inhibitory function of CD274/PD-L1/B7-H1, it can potentially restore the balance of the immune system and alleviate symptoms of autoimmune disorders.
Our antibody has been rigorously tested and validated for use in various experimental techniques, including Western blotting, immunofluorescence, and immunohistochemistry. Its high specificity and sensitivity ensure reliable and reproducible results.
Don’t miss out on the opportunity to advance your biotech research with our Anti-Tupaia chinensis CD274/PD-L1/B7-H1 Polyclonal Antibody. Order now and unlock the potential of this powerful tool in your experiments.
Keywords: Anti-Tupaia chinensis CD274/PD-L1/B7-H1 Polyclonal Antibody, biotech research, immune responses, cancer research, autoimmune disease research, experimental techniques, specificity, sensitivity, reliable, reproducible.
There are no reviews yet.